90 related articles for article (PubMed ID: 2968200)
1. Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.
Filion LG; Saginur R; Szczerbak N
Clin Exp Immunol; 1988 Mar; 71(3):405-9. PubMed ID: 2968200
[TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
Bauer T; Jilg W
Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
[TBL] [Abstract][Full Text] [Related]
6. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.
Cupps TR; Gerin JL; Purcell RH; Goldsmith PK; Fauci AS
J Clin Invest; 1984 Oct; 74(4):1204-13. PubMed ID: 6332826
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
[TBL] [Abstract][Full Text] [Related]
8. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
9. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
11. Induction of the in vitro anti-HBs response by hepatitis B surface antigen.
Filion LG; Saginur R
Clin Exp Immunol; 1988 Dec; 74(3):321-5. PubMed ID: 2976620
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling.
Zou Q; Zhong Y; Su H; Kang Y; Jin J; Liu Q; Geng S; Zhao G; Wang B
Vaccine; 2010 Feb; 28(8):2032-8. PubMed ID: 20188260
[TBL] [Abstract][Full Text] [Related]
13. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to hepatitis B surface antigen in man.
Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
[TBL] [Abstract][Full Text] [Related]
15. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
Nyström J; Cardell K; Björnsdottir TB; Fryden A; Hultgren C; Sällberg M
Vaccine; 2008 Nov; 26(47):5967-72. PubMed ID: 18804140
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: limited usefulness of dendritic cells as signal enhancers.
Litjens NH; Huisman M; Baan CC; van Druningen CJ; Betjes MG
J Immunol Methods; 2008 Jan; 330(1-2):1-11. PubMed ID: 18061610
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
Celis E; Kung PC; Chang TW
J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
[TBL] [Abstract][Full Text] [Related]
18. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
20. Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.
Chiou SS; Yamauchi K; Nakanishi T; Obata H
Immunology; 1988 Jul; 64(3):545-50. PubMed ID: 3261712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]